NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) — Ready Capital Corporation (NYSE:RC) (the “Company”) announced that its Board of Directors declared a quarterly cash dividend of $0.30 per share of common stock and Operating Partnership unit for the quarter ended June 30, 2024. This dividend is payable on July 31, 2024, to shareholders of record as of the close of business on June 28, 2024.
Additionally, the Company announced that its Board of Directors declared quarterly cash dividends on its 6.25% Series C Cumulative Convertible Preferred Stock (the “Series C Preferred Stock”), and its 6.50% Series E Cumulative Redeemable Preferred Stock (the “Series E Preferred Stock”).
The Company declared a dividend of $0.390625 per share of Series C Preferred Stock payable on July 15, 2024, to Series C Preferred stockholders of record as of the close of business on June 28, 2024, which is the effective record date since June 30, 2024, is not a business day.
The Company declared a dividend of $0.40625 per share of Series E Preferred Stock payable on July 31, 2024, to Series E Preferred stockholders of record as of the close of business on June 28, 2024.
About Ready Capital Corporation
Ready Capital Corporation (NYSE: RC) is a multi-strategy real estate finance company that originates, acquires, finances and services lower-to-middle-market investor and owner occupied commercial real estate loans. The Company specializes in loans backed by commercial real estate, including agency multifamily, investor, construction, and bridge as well as U.S. Small Business Administration loans under its Section 7(a) program. Headquartered in New York, New York, the Company employs approximately 350 professionals nationwide.
Contact
Investor Relations
212-257-4666
InvestorRelations@readycapital.com
Media Relations
PR@readycapital.com
- Studies Uncover Hidden Urologic Risks—How Water, Chemicals and Everyday Exposures Impact Urinary Health - April 26, 2025
- RAINN Statement on the Passing of Virginia Giuffre - April 26, 2025
- Studies Unveil Groundbreaking Advances in Prostate Cancer: From AI-Driven Detection to Non-Invasive Testing - April 26, 2025
